Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 30 October 2026.

Announcements

6,259

Total raised

£165B

disclosed amounts

This month

£1.1B

raised so far

Seed
£250K

The Development Bank of Wales backed the fintech startup to accelerate its technology capabilities and create new jobs.

"Mobile wallets such as Apple Pay are growing in adoption but research shows that persoanlisation is a critical in the success of digital marketing. While customers want compelling content and a personalised experience, payment and financial apps are not currently meeting consumer expectation."
— Robert Dowd, CEO and Co-founder
Other
£250K

The equity investment follows an introduction by business angel Craig Gulliford.

"People want to gain more insight into their own health in order to reach their personal best. Our results dashboard is intuitive and easy to understand so that we can empower the consumer to understand more about their own body. Results of the at-home tests are processed within 48 hours via a personalised dashboard and I am proud to say that we are the only biomarker profiling company to offer our customer a mobile app."
— Sarah Bolt, CEO and Co-founder
Series A
£7.7M

The financing round was led by Beringea with participation from new and existing investors.

"Our goal as Second Nature is to solve obesity. We need to rise above the confusing health misinformation to provide clarity about what’s really important: changing habits. Our new brand and investment will help us realise that,"
— Mike Gibbs, Co-founder
Growth
£8.0M

LDC acquired a minority stake in the software reseller as previous backer BGF exited the business.

"We are experiencing growing demand for our services from a large, expanding customer base, many of whom have been with us for over 20 years. With the support of BGF over the last three years, we have been able to significantly grow our existing activities and acquire complementary businesses that are now core to the Solid Solutions family."
— Alan Sampson, Founder and CEO
Seed
£2.5M

The funding round was led by UK Innovation & Science Seed Fund with participation from LifeArc and Parkwalk.

"The increasing incidence of debilitating ophthalmic diseases brings morbidity and economic cost, and we are pleased to announce our seed funding today to tackle these urgent issues. We thank our investors UKI2S, LifeArc and Parkwalk for their support, and look forward to working with them to build Ikarovec into a leading gene therapy company."
— Robert Haigh, Executive Chairman